I will be happy if offer is much higher than $150. But realistically, I think ONXX and AMGN are very close to sealing the deal and this was the last item that will do it. I think ONXX and AMGN deal happens very soon. AZN is still doing due diligence but I doubt ONXX will wait for a bid to come from them given the leak that both ONXX and AMGN are OK with $130.
ONXX should show finger to AMGN for wasting valuable time
ONXX should focus on its business rather than on AMGN people. Let the game and dance end.
Unclear to me as well - do they want access to data before signing the agreement or after signing but before the closure of deal (2 to 3 months). Likely they want agreement to say that AMGN will get data before closure completion. ONXX probably does not want to add that to agreement because AMGN may use that as a reason to back out without/mitigated monetory repercussions to them. I think they have haggling over the fine print of the agreement. I think in the end a deal will be done at 130$ or higher. This leak may also be related to options expiration so people who are ready to take a additional risk may be able to make some money here IMO.
If Bayer is getting into the picture, IMO, it might be to buy out the Nexavar and Stivarga pieces. AMGN is probably more interested in Kyprolis and opro and less for other pieces. But not sure the impact if any of Bayer showing interest this late.
At cc, Bradway said they would like to acquire using their cash. Looking for growth potential.
Amgen has lot of cash! Great for ONXX
some analysts think amgen will be outbid by big pharma because of deeper pockets and better opportunities of synergy (combine with their existing sales force/setup) .
BoA Merill said even 140$ will be financially attractive for Amgen. Other analysts have said other players will win ultimately over Amgen because of deeper pockets or larger setup. That indicates to me that final price could be well above 140.
Shorts like you might get caught with pants down on Monday if we get some buyout news over the weekend
We have had three buy recently from analysts - Stephens, Janney Montgomery Scott and Longbow. Agreed they are not huge orgs but it is amazing that the price has fallen so rapidly from 5.80'ish to here so fast. Not sure whether it is small retail investors who are losing confidence and selling. I did see large buys around the time of the buy ratings - perhaps the big boys are accumulating in small lots while retailers are selling. Hopefully the next two quarters will show true potentail of OSUR and drive prices above 8.00.